Clearstead Advisors’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420 Buy
+8
New +$312 ﹤0.01% 2973
2026
Q1
– Sell
-174
Closed -$4.87K – 2265
2025
Q4
$4.87K Hold
174
– – ﹤0.01% 2022
2025
Q3
$5.22K Sell
174
-708
-80% -$20K ﹤0.01% 2144
2025
Q2
$25.2K Buy
882
+744
+539% +$22.1K ﹤0.01% 1528
2025
Q1
$4.56K Hold
138
– – ﹤0.01% 1769
2024
Q4
$3.97K Hold
138
– – ﹤0.01% 1757
2024
Q3
$3.86K Hold
138
– – ﹤0.01% 1750
2024
Q2
$3.33K Buy
+138
New +$3.38K ﹤0.01% 1757
2021
Q4
– Sell
-720
Closed -$22K – 1267
2021
Q3
$22K Buy
+720
New +$20.3K ﹤0.01% 779

Other funds holding ALKS

Clearstead Advisors's ALKS Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Alkermes (ALKS) in Q2 2026: 8 shares worth $420. The stake represents ﹤0.01% of the portfolio and ranks #2973 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ALKS as recently as Q4 2025.

Clearstead Advisors first reported a position in ALKS in Q3 2021 and has held it in 9 quarters since. The position peaked at $25.2K in Q2 2025. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Clearstead Advisors held 8 shares of Alkermes worth $420 as of Q2 2026.
  • Alkermes was a new Clearstead Advisors position in Q2 2026.
  • Alkermes made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2973 holding.
  • Clearstead Advisors first reported a position in Alkermes in Q3 2021 and has held it in 9 quarters since.
  • Clearstead Advisors's Alkermes position peaked at $25.2K in Q2 2025.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.